Although in recent years great progress has been made in brain tumor chemotherapy, this therapeutic approach appears to be conditioned by a large number of problems such as cell kinetics, tumor growth modalities, and drug delivery. Therefore only a small number of drugs (BCNU, CCNU, streptozocin, and procarbazine) clearly demonstrate effectiveness against these tumors. Immunotherapy raises the same and other problems.
|Translated title of the contribution||Chemotherapy and immunotherapy for malignant gliomas|
|Number of pages||8|
|Publication status||Published - 1984|
ASJC Scopus subject areas